Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R

被引:410
作者
Neely, Michael N. [1 ]
van Guilder, Michael G. [1 ]
Yamada, Walter M. [1 ]
Schumitzky, Alan [1 ]
Jelliffe, Roger W. [1 ]
机构
[1] Univ So Calif, Keck Sch Med, Lab Appl Pharmacokinet, Los Angeles, CA 90033 USA
基金
美国国家卫生研究院;
关键词
pharmacometrics; software; R; nonparametric; population modeling; MONTE-CARLO-SIMULATION;
D O I
10.1097/FTD.0b013e31825c4ba6
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
100118 [医学信息学]; 100208 [临床检验诊断学];
摘要
Introduction: Nonparametric population modeling algorithms have a theoretical superiority over parametric methods to detect pharmacokinetic and pharmacodynamic subgroups and outliers within a study population. Methods: The authors created "Pmetrics," a new Windows and Unix R software package that updates the older MM-USCPACK software for nonparametric and parametric population modeling and simulation of pharmacokinetic and pharmacodynamic systems. The parametric iterative 2-stage Bayesian and the nonparametric adaptive grid (NPAG) approaches in Pmetrics were used to fit a simulated population with bimodal elimination (Kel) and unimodal volume of distribution (Vd), plus an extreme outlier, for a 1-compartment model of an intravenous drug. Results: The true means (SD) for Kel and Vd in the population sample were 0.19 (0.17) and 102 (22.3), respectively. Those found by NPAG were 0.19 (0.16) and 104 (22.6). The iterative 2-stage Bayesian estimated them to be 0.18 (0.16) and 104 (24.4). However, given the bimodality of Kel, no subject had a value near the mean for the population. Only NPAG was able to accurately detect the bimodal distribution for Kel and to find the outlier in both the population model and in the Bayesian posterior parameter estimates. Conclusions: Built on over 3 decades of work, Pmetrics adopts a robust, reliable, and mature nonparametric approach to population modeling, which was better than the parametric method at discovering true pharmacokinetic subgroups and an outlier.
引用
收藏
页码:467 / 476
页数:10
相关论文
共 17 条
[1]
[Anonymous], 2011, R: A Language and Environment for Statistical Computing
[2]
Baek Y, 2006, THESIS U WASHINGTON
[3]
Pharmacometrics: A multidisciplinary field to facilitate critical thinking in drug development and translational research settings [J].
Barrett, Jeffrey S. ;
Fossler, Michael J. ;
Cadieu, K. David ;
Gastonguay, Marc R. .
JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (05) :632-649
[5]
Parametric and nonparametric population methods - Their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies [J].
Bustad, A ;
Terziivanov, D ;
Leary, R ;
Port, R ;
Schumitzky, A ;
Jelliffe, R .
CLINICAL PHARMACOKINETICS, 2006, 45 (04) :365-383
[6]
TRANSFORMATION TO NORMALITY OF NULL DISTRIBUTION OF G1 [J].
DAGOSTIN.RB .
BIOMETRIKA, 1970, 57 (03) :679-&
[7]
Population Modeling and Monte Carlo Simulation Study of the Pharmacokinetics and Antituberculosis Pharmacodynamics of Rifampin in Lungs [J].
Goutelle, Sylvain ;
Bourguignon, Laurent ;
Maire, Pascal H. ;
Van Guilder, Michael ;
Conte, John E., Jr. ;
Jelliffe, Roger W. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (07) :2974-2981
[8]
Achieving target goals most precisely using nonparametric compartmental models and "multiple model" design of dosage regimens [J].
Jelliffe, R ;
Bayard, D ;
Milman, M ;
Van Guilder, M ;
Schumitzky, A .
THERAPEUTIC DRUG MONITORING, 2000, 22 (03) :346-353
[9]
CONSISTENCY OF THE MAXIMUM-LIKELIHOOD ESTIMATOR IN THE PRESENCE OF INFINITELY MANY INCIDENTAL PARAMETERS [J].
KIEFER, J ;
WOLFOWITZ, J .
ANNALS OF MATHEMATICAL STATISTICS, 1956, 27 (04) :887-906
[10]
MALLET A, 1986, BIOMETRIKA, V73, P645